Navigating EUDR Compliance with Bayer: Impact on the Biopharma Supply Chain

🌍 Why EUDR Matters to You

The European Union Deforestation Regulation (EUDR) aims to combat global deforestation by requiring companies to ensure that their supply chains do not contribute to deforestation or forest degradation. While this regulation is enforced within the EU, its effects reach corporations operating there even if US-based.

For US-based Biopharma companies, this means:

• Starting Dec 30th 2024, affected companies must demonstrate adherence to several obligations regarding Due Diligence, Traceability and Reporting for certain products including rubber (stoppers, plungers, closures…) and palm oil (whose derivatives are used as excipients, lubricants, coatings, emulsifiers…).
• Supply Chain Scrutiny: Even if you don’t operate in the EU, your suppliers may be subject to EUDR, impacting your supply chain and operations.
• Increased Compliance Costs: Companies may face higher costs related to verifying and documenting the sustainability of their raw materials.
• Market Access: Compliance with EUDR can be crucial for accessing EU markets and maintaining a competitive edge globally.

By staying ahead of these regulations, you ensure that your business not only meets international standards but also strengthens its position as a leader in ESG practices.

🔍 What You Will Learn

• EUDR Overview: Understand the key aspects of the regulation, its implications for the Biopharma industry, and who must comply.
• Our Solution in Action: Patrick Lanz, our EUDR expert, will explain how our technology works and what you can expect from osapiens HUB in navigating EUDR compliance.
• Bayer’s Journey: Hear from Bayer about their EUDR challenges, their industry view point, how they benchmarked software solutions, and why they chose osapiens HUB.